By Katherine Hamilton
Bayer filed for the Supreme Court to review a lower court's decision on a case alleging the company's Roundup product caused cancer.
Bayer said Friday it had filed a petition for a writ of certiorari with the Supreme Court, arguing that a split among federal circuit courts in the Roundup litigation warrants review and resolution by the top court.
In 2023, a Missouri Circuit Court returned a verdict in favor of John Durnell, who alleged the weed control product Roundup caused non-Hodgkin's lymphoma. Bayer bought the agrochemical company Monsanto, which makes Roundup, in 2018.
The Missouri court's verdict rests on the claim that state law requires companies to warn if their products are carcinogenic, Bayer said.
Different courts have reached different conclusions, which is why Bayer is arguing the Supreme Court needs to rule on the issue.
Tens of thousands of Roundup cases are pending in state and federal courts. The ongoing litigation threatens Monsanto's ability to supply glyphosate-based products, Bayer said.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
April 04, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.